HRSA-22-072: Leadership Education in Adolescent Health (LEAH) Program
Closed
This grant is closed. A newer notice from the same program is open now: Women's Initiative for Screening and Health (WISH) (HRSA-27-072). Status: Closes January 8, 2027 (62 days left). It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make about 7 awards worth $3.2 million in total. Applications closed on February 15, 2022.
From the official notice on Grants.gov, last changed January 6, 2022. Checked November 7, 2026.
- Total funding$3.2 million
- Expected awards7
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | November 3, 2021 |
|---|---|
| Deadline | February 15, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include domestic public and nonprofit private institutions of higher learning. Only institutions of higher learning may apply for training grants (See 42 CFR § 51a.3(b)). For purposes of this funding opportunity, an “institution of higher learning" is defined as any college or university accredited by a regionalized body or bodies approved for such purpose by the Secretary of Education, and any teaching hospital which has higher education among its purposes and functions and which has a formal affiliation with an accredited school of medicine and a full-time academic medical staff holding faculty status in such school of medicine.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the Leadership Education in Adolescent Health (LEAH) Program. The purpose of the LEAH Program is to improve the quality of care and equitable access to appropriate health services for adolescents and young adults (AYA) by preparing leaders in AYA health through interdisciplinary training at the graduate and post-graduate levels. This is accomplished through five (5) overarching objectives to: (1) Prepare diverse AYA health professionals, through didactic, experiential, and research-based interdisciplinary education and training in core health disciplines of medicine, nursing, nutrition, psychology, and social work. (2) Expand diversity, equity, and inclusion related to race, ethnicity, geography, and special populations within all training program components, including but not limited to trainee/faculty recruitment, staffing plan, curricula, clinical and experiential activities, and research foci to address health disparities2 and increase health equity for AYA. (3) Develop curricula, training activities, and investigative research to produce evidence-based products and practices in primary care, AYA specialty service, and public health. (4) Improve access to behavioral, emotional, mental, developmental, and psychosocial health services, well-being, and support for AYA. (5) Develop, expand, and disseminate population-based strategies and effective practices through collaboration and coordination of telehealth, tele-education/distance learning, technical assistance (TA), and continuing education (CE).
Who has won Special Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Special Projects of Regional and National Significance (93.110) awarded $1.4 billion across 842 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Zero to Three National Center for Infants, Toddlers & Families | District of Columbia | 2 | $54.3 million |
| University Hospitals Cleveland Medical Center | Ohio | 1 | $51.5 million |
| Children's National Medical Center | District of Columbia | 1 | $37.2 million |
| University of North Carolina at Chapel Hill | North Carolina | 8 | $29.1 million |
| American Academy of Pediatrics | Illinois | 8 | $26.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-072, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-22-072 still open?
No. It closed on February 15, 2022. A newer notice is open: HRSA-27-072, closes January 8, 2027 (62 days left).
Who can apply for Leadership Education in Adolescent Health (LEAH) Program?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Leadership Education in Adolescent Health (LEAH) Program?
Closed February 15, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $3.2 million in total across about 7 awards.
Who has won Special Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)